-
Mar 05 2021Takeda secures global rights from Ovid Therapeutics to develop & commercialize soticlestat to treat Dravet syndrome and Lennox-Gastaut syndrome
Takeda Pharmaceutical Company Limited and Ovid Therapeutics, a biopharmaceutical company,…
Read more -
Mar 05 2021Boston to acquire global surgical business of Lumenis LTD from Baring Private Equity Asia
Boston Scientific Corporation announced that it has entered into a…
Read more -
Mar 05 2021Bio-Techne to acquire Austin, Texas-based biotechnology company, Asuragen for US$ 215 million
Bio-Techne Corporation, a global life sciences company, announced it has…
Read more -
Mar 05 2021Bio-Techne Corporation, a global life sciences company, announced it has reached an agreement to acquire Asuragen Inc, a biotechnology company for initial consideration of US$ 215 million in cash plus contingent
BioIVT, a leading provider of research models and services for…
Read more -
Mar 05 2021Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%
Bharat Biotech Announces Phase 3 Results of COVAXIN®:India’s First COVID-19…
Read more -
Mar 05 2021KITES Senior Care Launches Super Specialized Dementia & Alzheimer’s Care Centre for Elders
KITES Senior Care, a geriatric care specialist, unveiled an exclusive…
Read more -
Dec 29 2020Network 7 Media Group crown Industry Leaders at 11th Annual India Leadership Conclave ILC Power Brand Awards
Network 7 Media Group crown Industry Leaders at 11th Annual…
Read more -
Dec 23 2020Solomon Darwin, Dipak Gyawali, Rahul Chaudhary, Dharmender Kapoor, Rajan Sethuraman, Rajiv Nath set to address India Leadership Conclave 2020
Solomon Darwin, Dipak Gyawali, Rahul Chaudhary, Dharmender Kapoor, Rajan Sethuraman,…
Read more -
Nov 20 2020Medical Community & Policy Makers not in unanimity in the treatment of Mild to Moderate COVID-19 Patients
In India, which has the world’s second-largest COVID-19 outbreak, there…
Read more -
Oct 13 2020Bharat Biotech told to provide phase II data of Covaxin before phase III trial
Bharat Biotech, which had sought DCGI’s approval to conduct phase-3…
Read more
